[Congressional Record Volume 165, Number 163 (Wednesday, October 16, 2019)]
[House]
[Pages H8165-H8167]
From the Congressional Record Online through the Government Publishing Office [www.gpo.gov]




                ONDCP TECHNICAL CORRECTIONS ACT OF 2019

  Mr. ROUDA. Mr. Speaker, I move to suspend the rules and pass the bill 
(H.R. 3889) to amend the Office of National Drug Control Policy 
Reauthorization Act of 1998 to make technical corrections, as amended.
  The Clerk read the title of the bill.
  The text of the bill is as follows:

                               H.R. 3889

       Be it enacted by the Senate and House of Representatives of 
     the United States of America in Congress assembled,

     SECTION 1. SHORT TITLE.

       This Act may be cited as the ``ONDCP Technical Corrections 
     Act of 2019''.

     SEC. 2. TECHNICAL CORRECTIONS.

       (a) Office of National Drug Control Policy Reauthorization 
     Act of 1998 Technical Corrections.--The Office of National 
     Drug Control Policy Reauthorization Act of 1998 (21 U.S.C. 
     1701 et seq.) is amended--
       (1) by striking ``National Drug Control Program Agency'' 
     and inserting ``National Drug Control Program agency'' each 
     place it appears;
       (2) by striking ``National Drug Control Program Agencies'' 
     and inserting ``National Drug Control Program agencies'' each 
     place it appears;
       (3) in section 702(15), by striking ``tribal'' each place 
     it appears and inserting ``Tribal'';
       (4) in section 703--
       (A) in subsection (a)--
       (i) in paragraph (4), by striking ``program,'' and 
     inserting ``programs,''; and
       (ii) in paragraph (6), by striking ``High-Intensity'' and 
     inserting ``High Intensity''; and
       (B) in subsection (d), by striking ``chapter'' each place 
     it appears and inserting ``title'';
       (5) in section 704--
       (A) in subsection (a)(1)--
       (i) in subparagraph (C)--

       (I) in clause (i), by striking ``section 704(c)(4)'' and 
     inserting ``subsection (c)(5)''; and
       (II) in clause (iv), by striking ``section 704(j)'' and 
     inserting ``subsection (j)''; and

       (ii) in subparagraph (D)--

       (I) by striking ``The Director shall determine whether the 
     coordinator position is a noncareer'' and inserting ``For 
     purposes of carrying out the previous sentence, the Director 
     shall designate or appoint an''; and
       (II) by striking ``a career'' and inserting ``an'';

       (B) in subsection (b)(21)(A)(iii), by striking ``chapter'' 
     and inserting ``title'';
       (C) in subsection (c)--
       (i) in paragraph (2)(A)(ii), by striking ``fo'' and 
     inserting ``of'';
       (ii) in paragraph (3)(E)(ii)--

       (I) in subclause (I), by striking ``subparagraph (A)'' and 
     inserting ``clause (i)''; and
       (II) in subclause (II), by striking ``clause (i)'' and 
     inserting ``subclause (I)''; and

       (iii) in paragraph (5)(B)--

       (I) by striking ``The Director shall determine whether the 
     coordinator position is a noncareer'' and inserting ``For 
     purposes of carrying out subparagraph (A), the Director shall 
     designate or appoint an''; and
       (II) by striking ``a career'' and inserting ``an'';

       (D) in subsection (d)--
       (i) paragraph (8)--

       (I) in subparagraph (E)--

       (aa) in clause (iii), by moving subclauses (I) through (V) 
     two ems to the left so that the left margin of such clause is 
     aligned with the margin of clause (iii);
       (bb) by moving clause (iii) two ems to the left so that the 
     left margin of such clause is aligned with the margin of 
     subparagraph (E); and
       (cc) by redesignating clause (iii) as subparagraph (F); and

       (II) in subparagraph (F), as so redesignated--

[[Page H8166]]

       (aa) by redesignating subclauses (I) through (V) as clauses 
     (i) through (v), respectively; and
       (bb) in clause (v), as so redesignated, by striking the 
     period at the end and inserting a semicolon; and
       (ii) in paragraph (9), by striking ``section 704(f)(5);'' 
     and inserting ``subsection (f)(5); and''; and
       (E) in subsection (j)--
       (i) by striking ``The Director shall determine whether the 
     coordinator position is a noncareer'' and inserting ``For 
     purposes of carrying out the previous sentence, the Director 
     shall designate or appoint an'';
       (ii) by striking ``a career'' and inserting ``an''; and
       (iii) by inserting ``section'' before ``706'';
       (6) in section 705--
       (A) in subsection (d)(1), by striking ``that every'' and 
     inserting ``than every''; and
       (B) in subsection (f)--
       (i) in paragraph (1)--

       (I) in subparagraph (A)(i), by striking the semicolon at 
     the end and inserting ``; and''; and
       (II) in subparagraph (C)--

       (aa) by inserting ``that may impede applicants'' after 
     ``barriers''; and
       (bb) by striking ``impediments'' and all that follows 
     through ``agencies''; and
       (ii) in paragraph (2), in the heading, by striking ``drug 
     control'' and inserting ``drug control program'';
       (7) in section 707(o)(2)(B), by striking ``802(33))'' and 
     inserting ``802(33)))''; and
       (8) in section 709--
       (A) in subsection (a)--
       (i) in the heading, by inserting ``and Continuing'' before 
     ``Threats'';
       (ii) by striking ``The Director shall determine whether the 
     coordinator position is a noncareer'' and inserting ``For 
     purposes of carrying out the previous sentence, the Director 
     shall designate or appoint an''; and
       (iii) by striking ``a career'' and inserting ``an'';
       (B) in subsection (d)--
       (i) in paragraph (3)(F), by striking ``response of'' and 
     inserting ``response to''; and
       (ii) in paragraph (4)(B)(iii), by inserting ``the'' before 
     ``plan, where''; and
       (C) in subsection (f)(1), by striking ``subtitle'' and 
     inserting ``subsection''.
       (b) Repeal of Annual Report Requirement.--The Office of 
     National Drug Control Policy Reauthorization Act of 2006 
     (Public Law 109-469; 120 Stat. 3502) is amended--
       (1) by repealing section 203; and
       (2) in section 1(c), in the table of contents, by striking 
     the item relating to section 203.
       (c) Technical Correction to the Substance Abuse Prevention 
     Act of 2018.--
       (1) Amendments.--The Substance Abuse Prevention Act of 2018 
     (subtitle K of title VIII of Public Law 115-271) is amended--
       (A) in section 8203--
       (i) in subsection (a)--

       (I) in the heading, by striking ``National Narcotics 
     Leadership Act of 1988'' and inserting ``Anti-Drug Abuse Act 
     of 1988'';
       (II) in paragraph (1), by striking ``the National Narcotics 
     Leadership Act of 1988'' and inserting ``subtitle A of title 
     I of the Anti-Drug Abuse Act of 1988'';
       (III) by striking paragraph (3);
       (IV) by redesignating paragraph (4) as paragraph (3); and
       (V) in paragraph (3)(A), as so redesignated, by striking 
     ``National Narcotics Leadership Act of 1988'' and inserting 
     ``Anti-Drug Abuse Act of 1988'';

       (ii) in subsection (b)--

       (I) in the heading, by striking ``National Narcotics 
     Leadership Act of 1988'' and inserting ``Anti-Drug Abuse Act 
     of 1988'';
       (II) in the matter preceding paragraph (1), by striking 
     ``National Narcotics Leadership Act of 1988'' and inserting 
     ``Anti-Drug Abuse Act of 1988''; and
       (III) in paragraph (4)(B), by striking ``in section 
     1032(b)(1)(A) (21 U.S.C. 1532(b)(1)(A)), by striking clause 
     (iii) and inserting the following'' and inserting ``by 
     amending section 1032(b)(3)(D) (21 U.S.C. 1532(b)(3)(D)) to 
     read as follows''; and

       (iii) in the quoted matter added by subsection (b)(4)(B)--

       (I) in clause (iii), by moving subclauses (I) and (II) two 
     ems to the left so that the left margins of such subclauses 
     are aligned with the margin of clause (iii);
       (II) by moving clause (iii) two ems to the left so that the 
     left margin of such clause is aligned with the margin of 
     subparagraph (B) of subsection (b)(4);
       (III) by redesignating clause (iii) as subparagraph (D); 
     and
       (IV) in subparagraph (D), as so redesignated--

       (aa) by redesignating subclauses (I) and (II) as clauses 
     (i) and (ii), respectively; and
       (bb) in clause (ii), as so redesignated, by striking 
     ``tears'' and inserting ``years''; and
       (B) in section 8221--
       (i) in the quoted matter added by subsection (a), by 
     striking ```sec. 706. national drug control strategy.''; and
       (ii) in subsection (a), by striking ``amended to read as 
     follows:'' and inserting ``amended--
       ``(1) by striking subsections (a) and (b);
       ``(2) by redesignating subsections (c) and (d) as 
     subsections (h) and (i), respectively; and
       ``(3) by inserting before subsection (h), as so 
     redesignated, the following:''.
       (2) Effective date.--The amendments made by this subsection 
     shall take effect as if included in the enactment of the 
     Substance Abuse Prevention Act of 2018 (subtitle K of title 
     VIII of Public Law 115-271).
       (3) Matching requirement revived and restored.--Section 
     1032(b)(1)(A)(iii) of the Anti-Drug Abuse Act of 1988 (21 
     U.S.C. 1532(b)(1)(A)) is revived and restored as if the 
     amendment made by section 8203(b)(4) of the Substance Abuse 
     Prevention Act of 2018 (subtitle K of title VIII of Public 
     Law 115-271) had never been enacted.
       (d) Additional Technical Corrections to the Office of 
     National Drug Control Policy Reauthorization Act of 1998.--
     Section 706 of the Office of National Drug Control Policy 
     Reauthorization Act of 1998 (21 U.S.C. 1701 et seq.) is 
     amended--
       (1) in subsection (c)(1)(N)--
       (A) in clause (ii), by striking ``Programs'' and inserting 
     ``Program agencies''; and
       (B) in clause (iii), by striking ``Agencies'' and inserting 
     ``Program agencies'';
       (2) in subsection (c)(2), in the matter preceding 
     subparagraph (A), by striking ``paragraph (1)'' and inserting 
     ``paragraph (1)(M)'';
       (3) in subsection (f)--
       (A) in paragraph (2), by striking ``office'' and inserting 
     ``Office''; and
       (B) in paragraph (3)(A)(ii)--
       (i) in subclause (III), by striking the semicolon at the 
     end and inserting ``; and''; and
       (ii) in subclause (IV), by striking the semicolon at the 
     end and inserting a period; and
       (4) in subsection (g)(3), in subparagraph (B), by striking 
     ``chapter;'' and inserting ``title;''.
       (e) Administration of Grant.--Section 4 of Public Law 107-
     82 (21 U.S.C. 1521 note) is amended--
       (1) in subsection (a)--
       (A) by striking ``The Director'' and inserting ``Beginning 
     in fiscal year 2020, the Director''; and
       (B) by striking ``, using amounts authorized to be 
     appropriated by subsection (d),''; and
       (2) by amending subsection (d) to read as follows:
       ``(d) Administration of Grant.--
       ``(1) Duration.--With respect to a grant made under 
     subsection (a) in fiscal year 2020, the term of the grant 
     shall be 4 years.
       ``(2) Disbursement.--To the extent amounts are provided in 
     appropriation Acts for such grant, the Director shall 
     disburse the amount of the grant made under subsection (a) on 
     an annual basis.''.

  The SPEAKER pro tempore. Pursuant to the rule, the gentleman from 
California (Mr. Rouda) and the gentleman from Arizona (Mr. Gosar) each 
will control 20 minutes.
  The Chair recognizes the gentleman from California.


                             General Leave

  Mr. ROUDA. Mr. Speaker, I ask unanimous consent that all Members may 
have 5 legislative days in which to revise and extend their remarks and 
include extraneous material on this measure.
  The SPEAKER pro tempore. Is there objection to the request of the 
gentleman from California?
  There was no objection.
  Mr. ROUDA. Mr. Speaker, I yield myself such time as I may consume.
  Mr. Speaker, I am proud to support this bipartisan legislation that 
will make technical changes to the reauthorization of the Office of 
National Drug Control Policy included in last year's SUPPORT Act.
  As we all know, we are in the midst of a substance use disorder 
epidemic fueled by the proliferation of opioids, exacerbated by 
synthetic opioids like fentanyl, and increased use of methamphetamines, 
among other threats.
  This year, Americans will lose close to 70,000 friends and family and 
loved ones due to drug overdoses. More Americans are now dying annually 
due to overdose than at the height of the AIDS crisis or during the 
entire Vietnam war.
  No community is unaffected by the crisis. In my home of Orange 
County, California, drug and alcohol overdose deaths have increased by 
82 percent since 2000. Across our country, our constituents are asking 
us to advance solutions to address this epidemic.
  Last year, Congress passed and President Trump signed the SUPPORT for 
Patients and Communities Act, a wide-ranging, bipartisan bill aimed at 
addressing treatment, prevention, recovery, and enforcement.
  The SUPPORT Act represents an important step in the right direction 
to reverse the tide of overdose deaths. The SUPPORT Act included 
provisions to reauthorize and reform the Office of National Drug 
Control Policy, a component of the Executive Office of the President.
  ONDCP plays a critical role in overseeing the Federal Government's 
drug control efforts. However, there were several technical issues in 
the SUPPORT Act that must be corrected to ensure that the office can 
properly carry out its duties as Congress intended and improve the 
Federal Government's response to this crisis.

[[Page H8167]]

  The ONDCP Technical Corrections Act of 2019 would ensure the 
integrity of the performance measurement system, help ONDCP hire the 
best people to address the addiction crisis, and improve the 
effectiveness of grant programs. These corrections would help ONDCP's 
efficient and effective execution of its mission: preventing, 
combating, and treating the effects of drug proliferation throughout 
our Nation.
  I thank the gentleman from North Carolina (Mr. Meadows), my fellow 
Member, for joining me in introducing this bill and the committee staff 
on both sides of the aisle for working diligently to develop and 
advance it. I look forward to the House of Representatives passing this 
bill today.
  There is much more to be done to address the addiction crisis, and I 
look forward to continued work with all of my colleagues on this 
important issue.
  Mr. Speaker, I reserve the balance of my time.
                                         House of Representatives,


                             Committee on Energy and Commerce,

                                 Washington, DC, October 15, 2019.
     Hon. Elijah E. Cummings,
     Chair, Committee on Oversight and Reform,
     Washington, DC.
       Dear Chairman Cummings: I write concerning H.R. 3889, the 
     ``ONDCP Technical Corrections Act of 2019,'' which was 
     additionally referred to the Committee on Energy and 
     Commerce.
       In recognition of the desire to expedite consideration of 
     H.R. 3889, the Committee on Energy and Commerce agrees to 
     waive formal consideration of the bill as to provisions that 
     fall within the Rule Xjurisdiction of the Committee on Energy 
     and Commerce. The Committee takes this action with the mutual 
     understanding that we do not waive any jurisdiction over the 
     subject matter contained in this or similar legislation, and 
     that the Committee will be appropriately consulted and 
     involved as this bill or similar legislation moves forward so 
     that we may address any remaining issues within our 
     jurisdiction. I also request that you support my request to 
     name members of the Committee on Energy and Commerce to any 
     conference committee to consider such provisions.
       Finally, I would appreciate the inclusion of this letter 
     into the Congressional Record during floor consideration of 
     H.R. 3889.
           Sincerely,
                                               Frank Pallone, Jr.,
     Chairman.
                                  ____

                                         House of Representatives,


                            Committee on Oversight and Reform,

                                 Washington, DC, October 16, 2019.
     Hon. Frank Pallone, Jr.,
     Chairman, Committee on Energy and Commerce,
     House of Representatives, Washington, DC.
       Dear Chairman Pallone: Thank you for your letter regarding 
     H.R. 3889, the ONDCP Technical Corrections Act of 2019. As 
     you know, the bill was referred primarily to the Committee on 
     Oversight and Reform with an additional referral to the 
     Committee on Energy and Commerce.
       I thank you for allowing the Committee on Energy and 
     Commerce to be discharged from further consideration of the 
     bill to expedite floor consideration. This discharge in no 
     way affects your jurisdiction over the subject matter of the 
     bill, and it will not serve as precedent for future 
     referrals. In addition, should a conference on the bill be 
     necessary, I would support your request to have the Committee 
     on Energy and Commerce represented on the conference 
     committee.
       I would be pleased to include this letter and any response 
     in the Congressional Record during floor consideration to 
     memorialize our understanding.
           Sincerely,
                                               Elijah E. Cummings,
                                                         Chairman.

  Mr. GOSAR. Mr. Speaker, I yield myself such time as I may consume.
  Mr. Speaker, I rise in support of H.R. 3889, the ONDCP Technical 
Corrections Act of 2019. Simply, this bill makes technical amendments 
to a law we passed last Congress.
  We moved quickly last Congress to reauthorize the Office of National 
Drug Control Policy. The reauthorization was drafted to reinvigorate 
the office and give the Trump administration additional authorities to 
address the opioid crisis.
  Last Congress, the Committee on Oversight and Reform worked across 
party lines on a policy solution. President Trump appointed Jim Carroll 
to lead that office. The Senate confirmed his nomination earlier this 
year.
  Since then, Director Carroll has twice testified before the Committee 
on Oversight and Reform about the good work the administration is doing 
to combat the crisis. This bill will help to further support this 
administration's good work.
  I want to congratulate the gentleman from California (Mr. Rouda) for 
his good work on this bill, and I urge my colleagues to support it.
  Mr. Speaker, I yield back the balance of my time.
  Mr. ROUDA. Mr. Speaker, I yield back the balance of my time.
  The SPEAKER pro tempore. The question is on the motion offered by the 
gentleman from California (Mr. Rouda) that the House suspend the rules 
and pass the bill, H.R. 3889, as amended.
  The question was taken; and (two-thirds being in the affirmative) the 
rules were suspended and the bill, as amended, was passed.
  A motion to reconsider was laid on the table.

                          ____________________